[Thrombophlebitis--use of vitamin K antagonists].
Schwieder
G
G
Bereich Hämatologie/Onkologie, Medizinische Klinik I, Medizinische Universität zu Lübeck.
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D012307:Risk Factors; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D014812:Vitamin K